2.3! Caractéristiques de l'atteinte rénale à la phase aiguë ,
,
72! 8.1! Annexe 1 : Fiche information Santé Publique France ,
, , 1955.
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome, Lancet Lond Engl, vol.365, pp.1073-1086, 2005. ,
Haemolytic uraemic syndrome, The Lancet, vol.390, pp.681-696, 2017. ,
URL : https://hal.archives-ouvertes.fr/inserm-02155934
Paediatric haemolytic uraemic syndrome related to Shiga toxin-producing Escherichia coli, an overview of 10 years of surveillance in France, Euro Surveill Bull Eur Sur Mal Transm Eur Commun Dis Bull, vol.24, 2007. ,
URL : https://hal.archives-ouvertes.fr/hal-02153948
Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome, Pathol Biol, vol.63, pp.136-143, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01460643
Hemolytic uremic syndrome due to Shiga toxin-producing Escherichia coli infection, Med Mal Infect, vol.48, pp.167-174, 2018. ,
Global incidence of human Shiga toxin-producing Escherichia coli infections and deaths: a systematic review and knowledge synthesis, Foodborne Pathog Dis, vol.11, pp.447-455, 2014. ,
,
Extrarenal manifestations of the hemolytic uremic syndrome associated with Shiga toxin-producing Escherichia coli (STEC HUS), Pediatr Nephrol Berl Ger, 2018. ,
Renal and neurological involvement in typical Shiga toxin-associated HUS, Nat Rev Nephrol, vol.8, pp.658-669, 2012. ,
Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome, Clin J Am Soc Nephrol CJASN, vol.5, pp.1218-1228, 2010. ,
Extrarenal involvement in diarrhoea-associated haemolytic-uraemic syndrome, Pediatr Nephrol Berl Ger, vol.9, pp.117-119, 1995. ,
Acute neurology and neurophysiology of haemolytic-uraemic syndrome, Arch Dis Child, vol.84, pp.434-435, 2001. ,
Neurological involvement in hemolyticuremic syndrome, Ann Neurol, vol.19, pp.90-93, 1986. ,
Gastrointestinal manifestations of hemolytic uremic syndrome: recognition of pancreatitis, J Pediatr Gastroenterol Nutr, vol.11, pp.518-524, 1990. ,
, , 1999.
, Arch Pediatr Organe Off Soc Francaise Pediatr, vol.6, pp.430-433
Myocarditis and haemolytic uraemic syndrome, Arch Dis Child, vol.72, pp.46-47, 1995. ,
Cardiac tamponade as a terminal event in the hemolytic uremic syndrome in childhood, Pediatr Nephrol Berl Ger, vol.8, pp.754-755, 1994. ,
Direct cardiac involvement in childhood hemolyticuremic syndrome: case report and review of the literature, Eur J Pediatr, vol.175, pp.1927-1931, 2016. ,
Cardiac ischemia during hemolytic uremic syndrome, Pediatr Nephrol Berl Ger, vol.18, pp.286-289, 2003. ,
Shigatoxin-associated hemolytic uremic syndrome: current molecular mechanisms and future therapies, Drug Des Devel Ther, vol.6, pp.195-208, 2012. ,
Pathogenic role of inflammatory response during Shiga toxin-associated hemolytic uremic syndrome (HUS), 2018. ,
, Pediatr Nephrol Berl Ger, vol.33, pp.2057-2071
Shigatoxin-induced endothelin-1 expression in cultured podocytes autocrinally mediates actin remodeling, Am J Pathol, vol.169, pp.1965-1975, 2006. ,
Inhibition of water absorption in human proximal tubular epithelial cells in response to Shiga toxin-2, Pediatr Nephrol Berl Ger, vol.23, pp.1981-1990, 2008. ,
Apoptosis of renal tubular cells in, 2001. ,
, Shiga-toxin-mediated hemolytic uremic syndrome, Nephron, vol.87, pp.182-185
Induction of apoptosis in human renal, 1999. ,
Relationship between red blood cell transfusion requirements and severity of renal disease during the acute stage of hemolytic uremic syndrome, Pediatr Nephrol Berl Ger, vol.30, pp.2115-2119, 2015. ,
Treatment and management of children with haemolytic uraemic syndrome, Arch Dis Child, vol.103, pp.285-291, 2018. ,
Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome, Pediatr Nephrol Berl Ger, vol.28, pp.919-925, 2013. ,
Strain-specific differences in the, 1998. ,
, Dis Off Publ Eur Soc Clin Microbiol, vol.17, pp.761-766
Humoral immune response to, 2014. ,
, Shiga Toxin 2 (Stx2) among Brazilian urban children with hemolytic uremic syndrome and healthy controls, BMC Infect Dis, vol.14, p.320
, Risk Factors for Shiga Toxin, 2014.
, Producing Escherichia coli-Associated Human Diseases. Microbiol Spectr, vol.2
Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.55, pp.33-41, 2012. ,
Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Pediatr Infect Dis J, vol.31, pp.37-41, 2012. ,
Therapy: Azithromycin and decolonization after HUS, Nat Rev Nephrol, vol.8, pp.317-318, 2012. ,
Association between azithromycin therapy and duration of bacterial shedding among patients with Shiga toxin-producing enteroaggregative Escherichia coli O104:H4, JAMA, vol.307, pp.1046-1052, 2012. ,
,
German outbreak of Escherichia coli O104:H4 associated with sprouts, N Engl J Med, vol.365, pp.1763-1770, 2011. ,
, , 2016.
, Hemolytic Uremic Syndrome. Pediatrics, vol.137
Complications of apheresis in children, 2007. ,
, Transfusion (Paris), vol.47, pp.1837-1842
, , 1984.
, Arch Fr Pediatr, vol.41, pp.15-19
Heparin plus dipyridamole in childhood hemolytic-uremic syndrome: a prospective, randomized study, J Pediatr, vol.113, pp.913-918, 1988. ,
An evaluation of treatment with heparin in the haemolyticuraemic syndrome successfully treated by peritoneal dialysis, Arch Dis Child, vol.55, pp.393-397, 1980. ,
The use of intravenous, 1991. ,
New equations to estimate GFR in children with CKD, J Am Soc Nephrol JASN, vol.20, pp.629-637, 2009. ,
Diagnosis and management of chronic kidney disease in children: Guidelines of the French Society of Pediatric Nephrology, Arch Pediatr Organe Off Soc Francaise Pediatr, vol.23, pp.1191-1200, 2016. ,
Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience, Clin Exp Nephrol, vol.21, pp.889-894, 2017. ,
Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections, Pediatrics, vol.100, p.12, 1997. ,
The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections, N Engl J Med, vol.342, pp.1930-1936, 2000. ,
Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis, JAMA, vol.288, pp.996-1001, 2002. ,
Disease severity of Shiga toxin-producing, 2016. ,
O157 and factors influencing the development of typical haemolytic uraemic syndrome: a retrospective cohort study, BMJ Open, vol.6, p.9933, 2009. ,
Bleeding risk for surgical dialysis procedures in children with hemolytic uremic syndrome, Pediatr Nephrol Berl Ger, vol.25, pp.1693-1698, 2010. ,
Different classes of antibiotics differentially influence shiga toxin production, Antimicrob Agents Chemother, vol.54, pp.3790-3798, 2010. ,
Subtype-specific suppression of Shiga toxin 2 released from Escherichia coli upon exposure to protein synthesis inhibitors, J Clin Microbiol, vol.46, pp.2987-2991, 2008. ,
Eculizumab in severe, 2011. ,
, Shiga-toxin-associated HUS, N Engl J Med, vol.364, pp.2561-2563
Is eculizumab efficacious in Shigatoxinassociated hemolytic uremic syndrome? A narrative review of current evidence, Eur J Pediatr, vol.177, pp.311-318, 2018. ,
Eculizumab treatment in severe pediatric STEC-HUS: a multicenter retrospective study, Pediatr Nephrol, vol.33, pp.1385-1394, 2018. ,
An outbreak of Shiga toxin-producing, 2012. ,
, Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.55, pp.753-759
Use of complement monoclonal antibody eculizumab in Shiga toxin producing Escherichia coli associated hemolytic uremic syndrome: A review of current evidence, Pediatr Blood Cancer, vol.66, p.27913, 2019. ,
Outbreak of Escherichia coli O104:H4 haemolytic uraemic syndrome in France: outcome with eculizumab, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, vol.29, pp.565-572, 2014. ,
Intermediate Follow-up of Pediatric Patients With Hemolytic Uremic Syndrome During the 2011 Outbreak Caused by E. coli O104:H4, Clin Infect Dis Off Publ Infect Dis Soc Am, vol.64, pp.1637-1643, 2017. ,
Outcome of children with Shiga toxin-associated haemolytic uraemic syndrome treated with eculizumab: a matched cohort study, Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc -Eur Ren Assoc, 2019. ,
Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology, Pediatr Nephrol Berl Ger, vol.2, pp.279-285, 1988. ,
Plasma infusion for hemolyticuremic syndrome in children: results of a multicenter controlled trial, J Pediatr, vol.112, pp.284-290, 1988. ,
Management of an acute outbreak of diarrhoea-associated haemolytic uraemic syndrome with early plasma exchange in adults from southern Denmark: an observational study, Lancet Lond Engl, vol.378, pp.1089-1093, 2011. ,
Immunoadsorption in patients with haemolytic uraemic syndrome, Lancet Lond Engl, vol.379, pp.517-518, 2012. ,
Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial, Lancet Lond Engl, vol.378, pp.1166-1173, 2011. ,
, Diarrhea-associated hemolytic uremic Nephrol, vol.29, pp.711-714, 2016.
Long-term outcomes of, 2013. ,
, Shiga toxin hemolytic uremic syndrome, Pediatr Nephrol Berl Ger, vol.28, pp.2097-2105
Long-term renal prognosis of diarrheaassociated hemolytic uremic syndrome: a systematic review, meta-analysis, and metaregression, JAMA, vol.290, pp.1360-1370, 2003. ,
Long-term course and mechanisms of progression of renal disease in hemolytic uremic syndrome, Kidney Int Suppl, pp.102-106, 2005. ,
Development of focal segmental sclerosis and hyalinosis in hemolytic uremic syndrome, Pediatr Nephrol Berl Ger, vol.10, pp.687-692, 1996. ,
Podocyte depletion causes glomerulosclerosis: diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene, J Am Soc Nephrol JASN, vol.16, pp.2941-2952, 2005. ,
The podocyte's response to injury: role in proteinuria and glomerulosclerosis, Kidney Int, vol.69, pp.2131-2147, 2006. ,
Mechanisms of progression of chronic kidney disease, Pediatr Nephrol Berl Ger, vol.22, pp.2011-2022, 2007. ,
Fathallah-Shaykh SA (2017) Proteinuria and progression of pediatric chronic kidney disease: lessons from recent clinical studies, Pediatr Nephrol Berl Ger, vol.32, pp.743-751 ,
Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease, Kidney Int, vol.60, pp.1131-1140, 2001. ,
Diagnostic et prise en charge de la maladie rénale chronique de l'enfant : recommandations de la Société de néphrologie pédiatrique (SNP), Arch Pédiatrie, vol.23, pp.1191-1200, 2016. ,
Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy, Pediatr Nephrol Berl Ger, vol.26, pp.1247-1254, 2011. ,
Prognostic significance of microalbuminuria in postdiarrheal hemolytic uremic syndrome, Pediatr Nephrol Berl Ger, vol.22, pp.117-120, 2007. ,
Blood pressure in the long-term follow-up of children with hemolytic uremic syndrome, Pediatr Nephrol Berl Ger, vol.19, pp.1241-1244, 2004. ,
Ambulatory blood pressure monitoring after recovery from hemolytic uremic syndrome, Pediatr Nephrol Berl Ger, vol.16, pp.812-816, 2001. ,
Risk Factors for Short-and Long-Term Outcomes in Children With STEC-HUS/D+ HUS: A Single-Center Experience, Glob Pediatr Health, vol.5, pp.2333794-18816920, 2018. ,
Short-and Long-Term Renal Outcome of, 2018. ,
, Syndrome in Childhood. Front Pediatr, vol.6, p.220
Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome, 2008. ,
, Pediatr Nephrol Berl Ger, vol.23, pp.1303-1308
Long-term outcome, 2019. ,